Seroprevalence of HSV-1 and HSV-2 antibodies in Canadian women screened for enrolment in a herpes simplex virus vaccine trial

International Journal of STD and AIDS

Volumn 24, Issue 5, 2013, Pages 345-349

  Gorfinkel, I S ^a   Aoki, F ^b   McNeil, S ^c   Dionne, M ^d   Shafran, S D ^e   Zickler, P ^f   Halperin, S ^g   Langley, J ^g   Bellamy, A ^h   Schulte, J ⁱ   Heineman, T ^j   Belshe, R ^k  

^a PrimeHealth Clinical Research   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c Canadian Center for Vaccinology   (Canada)

^d Departement de Sante Publique   (Canada)

^e UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^f TASC CMX Research Services Inc   (Canada)

^g DALHOUSIE UNIVERSITY   (Canada)

^h The EMMES Corporation   (Canada)

ⁱ NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^j GLAXOSMITHKLINE   (United States)

^k SAINT LOUIS UNIVERSITY   (United States)

more..

Author keywords

Canadian women; Herpes simplex 1; Herpes simplex 2; herpes virus; Herpevac Trial for Women; HSV 1; HSV 2; seroprevalence; Sexually transmitted infection; STI

Indexed keywords

HERPES SIMPLEX VACCINE; HERPES SIMPLEX VIRUS 1 ANTIBODY; HERPES SIMPLEX VIRUS 2 ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBODY SCREENING; ARTICLE; CANADA; CORRELATION ANALYSIS; DRUG EFFICACY; FEMALE; GOLD STANDARD; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY (TOPIC); NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL; SEROPREVALENCE; WESTERN BLOTTING;

CANADIAN WOMEN; HERPES SIMPLEX 1; HERPES SIMPLEX 2; HERPES VIRUS; HERPEVAC TRIAL FOR WOMEN; HSV-1; HSV-2; SEROPREVALENCE; SEXUALLY TRANSMITTED INFECTION; STI;

ADOLESCENT; ADULT; AGE FACTORS; ANTIBODIES, VIRAL; BLOTTING, WESTERN; CANADA; DOUBLE-BLIND METHOD; FEMALE; HERPES GENITALIS; HERPES SIMPLEX VIRUS VACCINES; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HUMANS; LOGISTIC MODELS; MASS SCREENING; PATIENT SELECTION; PREVALENCE; PROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; SOCIOECONOMIC FACTORS; URBAN POPULATION; YOUNG ADULT;

EID: 84887398644     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1177/0956462412472822     Document Type: Article

References (36)

1. Howard M,Sellors J,Jang D,Robinson N,Fearon M,Kaczorowski J,Chernesky M.Regional distribution of antibodies to herpes simplex virus type 1 (HSV-1) and HSV-2 in men and women in Ontario Canada.J Clin Micro. 2003;41:84-9.
2. Looker K,Garnett G,Schmid G.An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection.World Health Org Bull. 2008;86:805-12.
3. Gilbert M,Li X,Petric M,Krajden M,Isaac-Renton JL,Ogilvie G,Rekart ML.Using centralized laboratory data to monitor trends in herpes simplex virus type 1 and 2 infection in British Columbia and the changing etiology of genital herpes simplex virus type 1 and 2 infection in British Columbia and the changing etiology of genital herpes.Cndn Pub Health Assoc. 2011;:225-9.
4. Romanowski B,Myziuk L,Walmsley S, et al.Seroprevalence and risk factors for herpes simplex virus infection in a population of hiv -infected patients in Canada.Sex Transm Dis. 2009;36:165-9.
5. Singh AE,Ramanoswki B,Wong T,Gourishankar S,Myziuk L,Fenton J,Preiksaitis JK.Herpes simplex virus seroprevalence and risk factors in 2 Canadian sexually transmitted disease clinics.Sex Transm Dis. 2005;32:95-100.
6. Kropp R,Wong T,Burton S,Embree J,Steben M.Neonatal herpes simplex virus infections in Canada: results of a 3-year national prospective study.Pediatrics. 2006;117:1955-62.
7. Patrick D,Dawar M,Cook DA,Krajden M,Ng HC,Rekart ML.Antenatal seroprevalence of herpes simplex virus type 2 (HSV-2) in Canadian women: HSV-2 prevalence increases throughout reproductive years.Sex Transm Dis. 2001;28:424-8.
8. Corey L,Wald A,Celum C,Quinn T.The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics.J Acquir Immune Defic Syndr. 2004;35:435-45.
9. Mark H,Gilbert L,Nanda J.Psychosocial wellbeing and quality of life among women newly diagnosed with genital herpes.J Obstet Gynelcol Neonatal Nurs. 2009;38:320-6.
10. Belshe R,Leone P,Bernstein D, et al.Efficacy results of a trial of a herpes simplex vaccine.N Engl J Med. 2012;366:34-43.
11. Ashley R,Militoni J.Use of densitometric analysis for interpreting HSV serologies based on Western blot.J Virol Methods. 1987;18:159-68.
12. Ashley R,Militoni J,Lee F,Nahmias A,Corey L.Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera.J Clin Microbiol. 1988;26:662-7.
13. Ashley R,Cent A,Maggs V,Corey L.Inability of enzyme immunoassays to discriminate between infections with herpes simplex virus types 1 and 2.Ann Intern Med. 1991;115:520-6.
14. Safrin S,Arvin A,Mills J,Ashley R.Comparison of the Western immunoblot assay and a glycoprotein G enzyme immunoassay for the detection of serum antibodies to herpes simplex virus 2 in patients with AIDS.J Clin Microbiol. 1992;30:1312-4.
15. Sullender WM,Yasukawa L,Schwartz M,Pereira L,Hensleigh PA,Prober CG,Arvin AM.Type-specific antibodies to herpes simplex virus type 2 (HSV-2) glycoprotein G in pregnant women, infants exposed to maternal HSV-2 infection at delivery, and infants with neonatal herpes.J Infect Dis. 1988;157:164-71.
16. Ashley RLClinical Management of Herpesvirus Infections. Sacks SLWhitley RJStraus SE, ed. Washington, DC: IOS pres; 1995:137-71.
17. Tunback P,Bergstrom T,Claesson BA,Carlsson RM,Lowhagen GB.Early acquisition of herpes simplex virus type 1 antibodies in children - a longitudinal serological study.J Clin Virol. 2007;40:26-30.
18. Tunback P,Bergstrom T,Andersson AS,Nordin P,Krantz I,Lowhagen GB.Prevalence of herpes simplex virus antibodies in childhood and adolescence: a cross sectional study.Scand J Infect Dis. 2003;35:498-502.
19. Shirtcliff E,Coe C,Pollak S.Early childhood stress is associated with elevated antibody levels to herpes simplex virus type 1.Proc Natl Acad Sci USA. 2009;106:2963-7.
20. Dowd J,Zajacova A,Aiello A.Early origins of health disparities: burden of infection, health, and socioeconomic status in U.S. children.Soc Sci Med. 2009;68:699-707.
21. Gilbert M,Li X,Petric M.Using centralized laboratory data to monitor trends in herpes simplex virus type 1 and 2 infection in British Columbia and the changing etiology of genital herpes.Can J Public Health. 2011;109:225-9.
22. Forward KR,Lee SH.Predominance of herpes simplex virus type 1 from patients with genital herpes in Nova Scotia.Can J Infect Dis. 2003;14:94-6.
23. Ribes JA,Steele AD,Seabolt JP,Baker DJ.Six-year study of the incidence of herpes in genital and non-genital cultures in a central Kentucky medical center patient population.J Clin Microbiol. 2001;39:3321-5.
24. Roberts CM,Pfister JR,Spear SJ.Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students.Sex Transm Dis. 2003;30:797-800.
25. Mertz GJ,Benedetti J,Ashley R,Selke SA,Corey L.Risk factors for the sexual transmission of genital herpes.Ann Intern Med. 1992;116:197-202.
26. Christenson B,Bottiger M,Svensson A,Jeansson S.A 15-year surveillance study of antibodies to herpes simplex virus types 1 and 2 in a cohort of young girls.J Infect. 1992;25:147-54.
27. Federal government of Canada. Population and Dwelling Counts, for Canada and Census Subdivisions (Municipalities), 2001 and 1996 Censuses
28. Williams JR,Zenilman J,Nanda JP,Mark H.Recruitment strategies and motivations for sexually transmitted disease testing among college students.J Am coll health. 2008;57:357-60.
29. Brock BV,Selke S,Benedetti J,Douglas JM,Corey L.Frequency of asymptomatic shedding of herpes simplex virus in women with genital herpes.JAMA. 1990;263:418-20.
30. Expert working group for the Canadian guidelines on sexually transmitted infections. Canadian guidelines on sexually transmitted infections, Public Health Agency of Canada, updated January2008.
31. Steben M,Money D,Wong T, et al.Genital herpes: gynaecological aspects.JOGC. 2008;207:347-53.
32. U.S. Preventative Services Task Force recommendations for STI screening.Am Fam Physician. 2008;77:819-24.
33. Young R,Hodge D,Liesegang TJ,Baratz KH.Incidence, recurrence and outcomes of herpes simplex virus eye disease in Olmsted County, Minnesota, 1976-2007: the effect of oral antiviral prophylaxis.Arch Ophthalmol. 2010;128:1178-83.
34. Zimet G.Improving adolescent health: focus on HPV vaccine acceptance.J Adolesc Health. 2005;:S17-23.
35. Zimet G,Perkins S,Sturm LA,Bair RM,Juliar BE,Mays RM.Predictors of sti vaccine acceptability among parents and their adolescent children.J Adolesc Health. 2005;37:179-86.
36. Liddon N,Pulley L,Cockerham WC,Jueschen G,Vermund SH,Hook EW.Parents'/guardians' willingness to vaccinate their children against genital herpes.J Adolesc Health. 2005;37:187-93.